Amgen Inc (AMGN) 169.10 $AMGN Final Glance:

New Post Public Reply Private Reply Replies (0) Message Board

Apr 22, 2015 at 7:05 PM

Amgen Inc (AMGN) 169.10 $AMGN

Final Glance: Biotechnology companies
AP - 51 mins ago
NEW YORK (AP) — Shares of some top biotechnology companies were mixed at the close of trading:
GILD: 104.18 (-1.02), AMGN: 169.10 (+0.64), CELG: 115.54 (+0.72)

Pfizer's Cancer Drug Meets First Primary Endpoint in Phase III - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 1 hr 6 mins ago
Pfizer Inc.'s (PFE) phase III study on inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia (ALL) met the first primary endpoint.
BIIB: 423.57 (+1.46), PFE: 34.93 (+0.04), HZNP: 30.96 (+0.10), AMGN: 169.10 (+0.64)

Stocks Strengthen; Tesla Motors Rises On Battery News
at Investor's Business Daily - Wed Apr 22, 2:04PM CDT
Stocks strengthened in mixed volume going into the final hour of trading Wednesday. The Nasdaq and the Dow Jones industrial average each rose 0.5%, while the S&P 500 gained 0.6%. Volume was tracking higher on the NYSE and lighter on the Nasdaq in the...
TSLA: 219.44 (+10.03), V: 68.01 (+2.66), FB: 84.63 (+1.01), CMG: 641.23 (-51.29), ILMN: 190.04 (-9.27), AMGN: 169.10 (+0.64), WAB: 98.61 (+2.84), MA: 91.20 (+3.43)

Alnylam Reports Positive Patisiran Results, Shares Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 22, 1:02PM CDT
Alnylam Pharmaceuticals (ALNY) announced encouraging results from its phase II study on patisiran.
BIIB: 423.57 (+1.46), ALNY: 118.00 (-2.70), AMGN: 169.10 (+0.64), SNY: 51.59 (+0.03)

Midday Glance: Biotechnology companies
AP - Wed Apr 22, 12:39PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:
GILD: 104.18 (-1.02), AMGN: 169.10 (+0.64), CELG: 115.54 (+0.72)

Biotech Stock Roundup: Amgen Starts Earnings Season on Strong Note, Setbacks for Ampio & Athersys - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Apr 22, 12:21PM CDT
Amgen's (AMGN) first quarter 2015 results were impressive and the company raised its earnings outlook for the year.
BIIB: 423.57 (+1.46), ALNY: 118.00 (-2.70), GILD: 104.18 (-1.02), MDCO: 27.84 (+0.25), AMGN: 169.10 (+0.64), AMPE: 2.89 (+0.20), ABBV: 64.52 (+0.91), ATHX: 1.34 (+0.01)

Stocks Mildly Higher; China Nods To Visa, MasterCard
at Investor's Business Daily - Wed Apr 22, 10:53AM CDT
Stocks had trouble finding direction during the morning but were mildly higher going into the noon hour as a mixed bag of earnings reports dominated the action. The Nasdaq rose less than 0.1%; the S&P 500 and the Dow Jones industrial average gained...
V: 68.01 (+2.66), CMG: 641.23 (-51.29), ILMN: 190.04 (-9.27), AMGN: 169.10 (+0.64), MA: 91.20 (+3.43), YUM: 84.04 (+3.19)

Today's Market: Tech And Biotech Stocks In The News
Matthew Smith - at Seeking Alpha - Wed Apr 22, 10:08AM CDT

YHOO: 43.97 (-0.52), FB: 84.63 (+1.01), ALU: 4.12 (+0.09), BUNT: 52.95 (-1.24), AMGN: 169.10 (+0.64), TWTR: 51.73 (+0.41), MSFT: 42.99 (+0.36), NOK: 8.00 (+0.16), BUNL: 27.69 (-0.14), BABA: 82.05 (-0.37)

Early Glance: Biotechnology companies
AP - Wed Apr 22, 9:25AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:
GILD: 104.18 (-1.02), AMGN: 169.10 (+0.64), CELG: 115.54 (+0.72)

Amgen Earnings Reveals Ugly Truth About Drug Pricing and Sales 'Growth'
at The Street - Wed Apr 22, 9:18AM CDT
It's common for drug companies to raise the price of their existing products once or twice per year, every year. The price increases far outpace the rate of inflation.
BIIB: 423.57 (+1.46), GILD: 104.18 (-1.02), AMGN: 169.10 (+0.64), CELG: 115.54 (+0.72)

Stock Market News for April 22, 2015 - Market News
Zacks Equity Research - Zacks Investment Research - Wed Apr 22, 9:10AM CDT
Benchmarks finished Tuesday’s trading session mostly lower following a mixed bag of earnings reports
VRTX: 132.85 (+0.65), UTX: 116.96 (+0.01), KMB: 111.85 (-1.30), MYL: 72.40 (-1.67), AMGN: 169.10 (+0.64), XOM: 87.46 (+0.58), SLB: 92.16 (+0.87), RIG: 16.85 (-0.18), IBM: 165.36 (+1.10), EOG: 97.70 (+1.11), DD: 71.44 (+0.75), TEVA: 63.01 (-1.15), CVX: 109.50 (-0.23), REGN: 472.63 (+9.41), TRV: 102.02 (+0.14)

Amgen (AMGN) Crosses Pivot Point Resistance at $169.20
Comtex SmarTrend(R) - Wed Apr 22, 9:08AM CDT
Shares of Amgen (NASDAQ:AMGN) opened today above their pivot of $168.14 and have already reached the first level of resistance at $169.20. Should the shares continue to rise, the resistance pivots of $169.95 and $171.76 will be of interest.
AMGN: 169.10 (+0.64)

Actelion (ALIOF) Beats Q1 Earnings & Revenue Expectations - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 22, 8:50AM CDT
Actelion Ltd. (ALIOF) reported first-quarter 2015 earnings of $1.57 per ADR beating the Zacks Consensus Estimate of $1.28 per ADR.
BIIB: 423.57 (+1.46), HZNP: 30.96 (+0.10), AMGN: 169.10 (+0.64)

Critical Alerts For Celgene, Rambus, Mylan, Amgen and Zoetis Released By InvestorsObserver
PR Newswire - Wed Apr 22, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for CELG, RMBS, MYL, AMGN and ZTS.
ZTS: 47.03 (-0.51), AMGN: 169.10 (+0.64), MYL: 72.40 (-1.67), RMBS: 14.40 (+0.22), CELG: 115.54 (+0.72)

A Discussion Of Amgen's Q1 Results, With Updates On Its Pipeline
DoctoRx - at Seeking Alpha - Wed Apr 22, 8:28AM CDT

PFE: 34.93 (+0.04), AMGN: 169.10 (+0.64), LLY: 72.30 (+0.09), BMY: 66.60 (-0.21), SNY: 51.59 (+0.03), REGN: 472.63 (+9.41), HSP: 87.80 (+0.04), CELG: 115.54 (+0.72)

Amgen Beats on Q1 Earnings & Revenues, Ups Earnings View - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Apr 22, 8:15AM CDT
Amgen (AMGN) started 2015 on a strong note with earnings and revenues surpassing expectations.
BIIB: 423.57 (+1.46), OSIR: 16.35 (-0.10), AMGN: 169.10 (+0.64), NVS: 103.45 (-0.62)

Amgen (AMGN) Earnings Report: Q1 2015 Conference Call Transcript
at The Street - Wed Apr 22, 7:29AM CDT
The following Amgen (AMGN) conference call took place on April 21, 2015, 05:00 PM ET. This is a transcript of that earnings call:
AMGN: 169.10 (+0.64)

'Fast Money' Recap: How to Trade Yahoo!, Chipotle After Earnings
at The Street - Wed Apr 22, 4:00AM CDT
The trading panel looked at Yahoo!'s challenges, what to do with Yum! Brands and whether to buy Amgen.
JACK: 91.32 (-0.27), YHOO: 43.97 (-0.52), CMG: 641.23 (-51.29), MCD: 97.84 (+2.97), LOCO: 28.22 (-0.34), DD: 71.44 (+0.75), AMGN: 169.10 (+0.64), GOOGL: 549.18 (+6.26), YUM: 84.04 (+3.19), GSG: 20.72 (+0.02), BABA: 82.05 (-0.37)

Amgen's (AMGN) CEO Bob Bradway on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Apr 21, 8:18PM CDT

AMGN: 169.10 (+0.64)

Amgen tops estimates with 51 percent spike in 1Q profit
By LINDA A. JOHNSON - AP - Tue Apr 21, 6:27PM CDT
TRENTON, N.J. (AP) — Amgen Inc. boosted its first-quarter profit by 51 percent, thanks to surging drug sales and ongoing cost cuts designed to free up cash for an unprecedented burst of new product launches.
1 Comment
AMGN: 169.10 (+0.64), REGN: 472.63 (+9.41)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AB SKF to Hold EGM, Spin Off Automotive Assets

SKF's Extraordinary Meeting: A Pivotal Moment AB SKF, a heavyweight in the industrial technology sector, is summoning its shareholders for an Extraordinary General Meeting on October 1, 2026. The venue? The Elite Park Avenue Hotel in Gothenburg, Sweden—sounds fancy, but don't expect to hear a string quartet at this shindig. What's truly on the agenda is a critical...

Hoymiles' V2X Charger Revamps Home Energy Control

Revolutionizing Home Energy with Hoymiles Here's a twist in the world of home energy that'll make any enthusiast pause—Hoymiles has launched their V2X DC Charger. This little number isn’t just a step up; it’s a giant leap toward integrating electric vehicles (EVs) into your home's energy system like never before. Nestled in Hangzhou, they've rolled this out as a...

Huion Kamvas Pad 12: A Creative Power Tool

The Kamvas Pad 12 Hits the Market In a crowded tablet market that's fierce with innovation, Huion tossed their latest tool into the ring—the Kamvas Pad 12. Now, anyone who’s been watching the digital art scene won't be surprised that Huion, with its decade and a half of digital prowess, is pulling another tablet trick out of its hat. Key Features and Innovations If...

Cultural Convergence: Ordos Event Captivates Global Visitors

Ordos: Where Cultures Connect Seamlessly Spanning continents and cultures, the recent 'Warm City' event in Ordos, Inner Mongolia, drew international attention like bees to honey. Now, if you're thinking this is just another cultural shindig, think again. François Tchiegue, an ambassador of China-Africa cultural exchanges, described it best when he noted how the morin...

Moonlock: Award-Winning Design Elevates Cybersecurity's Importance

Design Excellence Meets Cybersecurity There's a new sheriff in town when it comes to cybersecurity design, and its name is Moonlock. MacPaw's antivirus and protection app pulled off a coup by bagging the 2026 Red Dot Award in the Interface & User Experience Design category. It's a big deal in the cybersecurity realm, where functionality often overshadows finesse. But...

Coastal Property Realities: A Deep Dive into Ownership

Buying Coastal Property: A Balancing Act Ah, the dream of owning a piece of the beach in sunny South Florida. It sounds glamorous—something to brag about at the next family gathering. But let me tell you, diving into coastal property ownership isn't just about sipping cocktails by the ocean. It's about handling a fair share of headaches most folks don't anticipate....

Sony Expands Versatile Wireless Headphone Lineup: 2026

Renewed Focus on Sound: Sony's Latest Headphones Sony's dipping into the headphone market this time with a splash of style and sound signature updates. We've got the WH-1000XM4C, a next-gen version of the top-dog noise-cancelling cans, that are gonna catch the eye of every audiophile and traveler out there. WH-1000XM4C: The Flagship gets a Lift What they're offering is...

Interventional Ophthalmology: Early Eye Care Strategies Evolve

Proactive Eye Care: The New Frontier Today's eye care landscape is all about catching things early, folks. Long gone are the days of waiting for eyesight to deteriorate before rushing to the nearest eye doc. In Racine, interventional ophthalmology is shifting gears towards preventive care—looking ahead to stop eye diseases in their tracks before they muck up a person's...

AION UT Sets New Safety Standard in Euro NCAP 2026

The New Gold Standard in Safety for Small EVs Hop into your favorite auto forum and you'll hear more than a buzz—it's a full-blown ruckus. The reason? GAC’s AION UT just nabbed a 2026 Euro NCAP Five-Star Safety Rating. Now, this isn’t just another accolade in a crowded trophy room; it’s a statement, a seismic shift in how small electric vehicles stack up in terms...

West Texas Weather Shapes Home Design Decisions

West Texas Weather: A Tough Customer for Home Builders You'd think building a house is a straightforward gig, but slap it down in West Texas, and we're talking a whole different ballgame. With its brutal heat, howling winds, and wild temperature swings, Odessa isn't just painting by numbers. It's where Mother Nature is your uninvited consultant on every single...